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Background: Sinonasal inverted papilloma (SNIP) is a benign but locally aggressive tumor 27 
that has a tendency toward recurrences and malignant transformation. The role of human 28 
papillomavirus (HPV) in SNIP is controversial. 29 
Objective: to determine the HPV-DNA prevalence and type distribution in SNIP in two 30 
different geographical areas, and to assess the association of HPV infection and other 31 
factors to recurrence. 32 
Methods: Two retrospective cohorts of SNIP patients from Poland and Spain were 33 
evaluated. Demographic, tobacco/alcohol use, clinical and follow-up data were collected. All 34 
samples were subject to histopathological evaluation, DNA quality control, and HPV-DNA 35 
detection by PCR. HPV-DNA positive samples and a random sample of HPV-DNA negative 36 
cases were further subject to p16INK4a analysis. Proportional-hazards models were used to 37 
evaluate the risk of recurrence by selected variables.  38 
Results: Seventy-nine SNIP patients (46 from Spain diagnosed between 1995 and 2014, 39 
and 33 from Poland diagnosed between 2012 and 2017) were included in the study. HPV-40 
DNA was detected in four patients (5.1%), two from each group, all four being positive for 41 
HPV11. Seventeen patients (21.5%) had recurrence, with a median time to recurrence of 14 42 
months. HPV-DNA positivity, toxic habits, Krouse stage or malignant transformation during 43 
follow-up were not observed to be associated with a higher risk of recurrence.  44 
Conclusion: The low prevalence of HPV-DNA found in SNIP suggests that HPV is not a 45 
main etiological factor for SNIP. The absence of association between the herein evaluated 46 
factors and recurrence may suggest the involvement of other factors, although further 47 
research with larger number of patients and additional biomarkers is warranted. 48 





































































The sinonasal inverted papilloma (SNIP) is a benign epithelial neoplasm that represents a 51 
0.5-4% of primary sinonasal tumors and has an incidence of 0.2-0.7/100.000 people/year. 52 
It tends to present local aggressiveness and recurrences after surgical removal and may 53 
have a malignant transformation [1]. 54 
Within the sinonasal tract, SNIP is more frequently found on the lateral wall of the nasal 55 
fossae, although the localization at the ethmoidal and maxillary sinuses is also very frequent. 56 
Histologically, SNIP is characterized by invagination of the hyperplastic epithelium, ranging 57 
from squamous to ciliated columnar with goblet cells into the underlying stroma (figure 1 and 58 
2). 59 
SNIP is the most common type of sinonasal papillomas, which are classified according to 60 
their histological structure in exophytic or fungiform papilloma, inverted papilloma, and 61 
cylindrical or oncocytic papilloma [2]. All types may coexist. SNIPs represent 70% of all 62 
sinonasal papillomas [3]. 63 
Although histologically benign, SNIP shows a propensity for malignant transformation, most 64 
frequently to squamous cell carcinoma (SCC). The rate of malignant association is 65 
approximately 10% [4,5]. The factors responsible for malignant transformation are not yet 66 
fully elucidated due to the relative low prevalence of SNIPs as well as of SCC arising in the 67 
sinonasal tract [4]. SNIP is also particularly prone to recurrence [2] although the postulated 68 
factors associated with recurrence such as human papillomavirus (HPV) infection [6], 69 
tobacco smoking [7] or Krouse stage [8] have not been consistently corroborated.   70 
The recommended treatment for SNIP is complete surgical excision by an endoscopic, open 71 
or combined approach [9]. Occupational exposures (organic solvents and welding fumes) 72 
have been reported to be implicated in the development of SNIP [2]. Chronic sinonasal 73 





































































The establishment of the role of HPV in a fraction of head and neck cancers (HNC) raised 76 
interest on the etiologic and prognostic role of HPV in other benign head and neck lesions 77 
such as SNIP. In the last decades, several studies have explored the relationship between 78 
SNIP and HPV infection, obtaining conflicting results. The detection rates of HPV in SNIP 79 
range from 0 to 100% in the world literature [1,2,10]. Such differences have not been 80 
explained by differences in geographical regions or HPV detection methods [10].  81 
Recently, last reports about the role of HPV in SNIP are proposing new theories postulating 82 
that the infection is not related to the initial pathogenesis of the SNIP but when there is an 83 
inflammatory and metaplastic mucosa, the virus is more susceptible to infect it [11]. 84 
Moreover, the presence of the virus in the SNIP has been related with a higher risk of 85 
recurrences [6] and malignant transformation (especially for high-risk genotypes 16 and 18) 86 
[1,12]. The unequivocal establishment of the prognostic HPV role in SNIPs, as well as other 87 
nasosinusal lesions, might have implications for tertiary prevention of recurrence or 88 
malignant transformation through HPV vaccination. 89 
This study aimed to estimate the HPV-DNA prevalence and type distribution in SNIP in two 90 
series from two different geographical areas, Spain and Poland, and to analyse risk factors 91 
for recurrence and malignant transformation in both groups.  92 
 93 
METHODS 94 
Study Design 95 
We carried out a retrospective study including two cohorts of all primary SNIPs diagnosed 96 
between 1995 and 2014 at the Department of otorhinolaryngology of the Hospital 97 
Universitari de Bellvitge (Spain) and between 2012 and 2017 at the Department of 98 
Otorhinolaryngology of the Czerniakowski Hospital in Warsaw (Poland). The pathologic 99 
diagnosis of the lesions was confirmed by biopsy. Demographic data and information about 100 




































































staging system [13] and follow-up was collected from medical records. Recurrent cases or 102 
cases previously undergoing nasal surgeries were excluded.  103 
Protocols were approved by the ethics committee of the Catalan Institute of Oncology-ICO 104 
(Comité Ètic d’Investigació Clínica de l’Hospital Universitari de Bellvitge, Spain), which 105 
required no informed consent to use archived samples. 106 
Formalin-fixed, paraffin-embedded (FFPE) blocks processing and histopathological 107 
evaluation 108 
Protocols have been described elsewhere [14]. Briefly, FFPE blocks were processed under 109 
strict conditions to avoid contamination and were re-embedded at ICO whenever necessary. 110 
At least four paraffin sections were obtained for each block. First and last sections were 111 
used for histopathological evaluation (sandwich method) after  hematoxylin and eosin (H&E) 112 
staining and the in-between ones for HPV testing and genotyping and expression of p16INK4a. 113 
FFPE blocks were processed under strict pre/post polymerase chain reaction (PCR) 114 
physical separation, and blank paraffin blocks were systematically tested in parallel to serve 115 
as sentinels for contamination as previously published [14]. Pathology review was performed 116 
using a form specifically designed by two pathologists for the study (see supplementary 117 
material) and blind with respect to the original local diagnosis. It followed a pre-established 118 
algorithm for diagnostic consensus involving the two pathologists. First, all pathology slides 119 
were reviewed by a trained pathologist at ICO. Samples with discordant diagnosis were 120 
further reviewed by the two pathologists for a final evaluation and agreed diagnosis.  121 
HPV-DNA Detection and Genotyping 122 
The detailed methods used for HPV-DNA detection and genotyping have been reported 123 
elsewhere [14]. Briefly, we used SPF-10 PCR and a DNA enzyme immunoassay (DEIA) to 124 
test for the presence of HPV-DNA. Virus genotyping was performed using reverse 125 
hybridization line probe assay (LiPA25_v1) on all samples testing positive for viral DNA, 126 




































































HPV-DNA negative samples by testing for the human tubulin gene [14]. All DEIA and 128 
LiPA25_v1 assays were performed at ICO.  129 
p16INK4a immunohistochemistry 130 
p16INK4a expression was evaluated on all HPV-DNA positive cases and a random sample of 131 
HPV-DNA negative cases using the CINtec histology kit (clone E6H4, Roche mtm 132 
laboratories AG, Germany), following the manufacturer’s protocol. A pattern of diffuse 133 
staining of more than 70% stained cells (nuclear and cytoplasmic) is considered positive for 134 
malignant lesions [15], but in our study we assumed as positive a staining between 26 and 135 
50% for premalignant lesions in a diffuse or continuous pattern [16,17]. 136 
 137 
Statistical analysis 138 
Descriptive statistics were computed for each of the variables analysed. Fisher’s exact test 139 
for categorical variables and t-test for continuous variables were used to detect statistically 140 
significant differences between the two centres for each variable. Median and range of 141 
months to recurrence and months of follow up variables were estimated. To compare 142 
medians between groups, qreg (quantile regression) test, equivalent to t-test for means, was 143 
employed. A survival analysis was conducted to identify variables associated with 144 
recurrence. Cox regression model was performed to estimate hazard ratios and their 95% 145 
CI. In order to avoid the possible bias due to the centre where the SNIPs were diagnosed 146 
and treated, centre was introduced as a strata variable allowing the baseline hazard function 147 
to differ for the different centre. Proportional hazard assumption was also verified. Due to 148 
the low number of cases progressing to invasive cancer during follow-up, survival analyses 149 
to identify variables associated with malignant transformation could not be performed. All 150 





































































Figure 3 depicts the disposition of SNIP samples collected, processed and tested. The ICO 153 
laboratory received 63 samples from Bellvitge Hospital (Spain) and 68 samples from 154 
Czerniakowski Hospital (Poland). A total of 79 cases (46 from Spain and 33 from Poland) 155 
were included in the final analysis, respectively. 156 
The characteristics of the patients are presented in Table 1. Most cases were males (67.1%) 157 
and non-drinkers (70.9%) with a mean age of 56.2 years. There was a higher proportion of 158 
ever-smokers in the Spanish group (67.4% vs 39.4%, p=0.010) whereas Polish cases were 159 
more frequently diagnosed with more advanced Krouse stages (p<0.001). Cases from both 160 
centres presented also differences regarding some histopathological variables, with more 161 
Polish cases presenting transitional epithelium (p=0.015) and more Spanish cases 162 
presenting squamous epithelium (p<0.001) and papillar or exophytic lesion adjacent to SNIP 163 
(p<0.001). The median time to follow-up was 76.63 months (range 0.23-174.3) for Spanish 164 
cases and 39.1 months (range 6.3-66.5) for Polish ones. Seventeen patients (21.5%) had 165 
recurrence, of which 12 were from Spain (26.1%) and 5 from Poland (15.2%), with a median 166 
time to recurrence of 14 months (range from 3 to 83). Only two cases (2.5%), both belonging 167 
to the Spanish series, progressed to invasive cancer during follow-up. HPV-DNA was 168 
detected in two samples (4.3%) in the Spanish series and in two samples (6.1%) in the 169 
polish series. All of them were positive for HPV11 and negative for p16INK4a high expression. 170 
All HPV-DNA negative cases tested for p16INK4a (20 cases, representing 27% of all HPV-171 
DNA negative cases) were also negative for p16INK4a high expression. 172 
 173 
 The presence of atypia adjacent to SNIP at diagnosis was the only statistically significant 174 
factor associated to recurrence with a crude hazard ratio (HR) of 18.83 (95%CI, 1.71-175 
207.65) (Table 2). The recurrence rate was higher in higher Krouse stages (T2 and T3) 176 
compared to T1, although not statistically significant. No significant differences in risk of 177 




































































risk-HPV positive SNIPs were located in the nasal cavity (one in the septum, one in the 179 
vestibulum and two in the lateral wall, and among those, one in the lower turbinate and one 180 
in the middle turbinate and middle meatus). None of them presented dysplasia. In contrast, 181 
most HPV-negative SNIPs were located at the lateral wall (85%), the maxillary sinus (15%) 182 
and the ethmoid sinus (20%), some of them affecting more than one location. HPV-positive 183 
patients were two males and two females, with a mean age of 37.8 years old at the moment 184 
of diagnosis. SNIPs recurred in 25% (1/4) of HPV-positive vs 22.2% (16/72) of HPV-negative 185 
lesions (crude HR=3.70, 95%CI 0.44–31.37). Recurrence univariate Cox models for tobacco 186 
use and Krouse stage were also performed stratified by centre, and statistically significant 187 
differences between both groups were not found. 188 
DISCUSSION 189 
The etiologic and prognostic role of HPV in SNIP remains unclear, with previous studies 190 
reporting HPV detection rates ranging from 0 to 100% [1,2,10,11] as well as contradictory 191 
results on the role of HPV infection in recurrence and malignant transformation of SNIP 192 
[1,6,12].The differences have not been explained by differences in geographical regions or 193 
HPV detection methods [10]. However, to the best of our knowledge, any study has 194 
evaluated cases from different geographical regions with the same sample processing and 195 
HPV detection protocol. Thus, our results add to current data from a systematic review [10], 196 
the only previous publication pooling results of studies from different geographical regions, 197 
since systematic reviews and meta-analyses are not exempt from limitations [18]. 198 
We herein evaluated the prevalence and prognostic role of HPV in two retrospective cohorts 199 
of primary SNIPs from Spain and Poland, as well as additional factors associated to 200 
recurrence. We tested the SNIPs cases following a previously validated robust, standardized 201 
and international protocol designed to provide estimates of HPV-attributable fractions in 202 




































































Our study is the first to evaluate SNIPs from two different geographical regions which have 204 
previously shown marked differences in HPV-AFs in OPC [14]. Our data demonstrates a 205 
low HPV-DNA detection (5.1%) in primary SNIPs, similar to the 4.9% estimated at the oral 206 
cavity of healthy population [19] or the 4% and 7% estimated at inflammatory nasal polyps 207 
and normal sinonasal mucosa, respectively [10], suggesting that HPV is not a main 208 
etiological factor for SNIP in either setting herein evaluated. Our HPV prevalence estimates 209 
are in accordance with those of previous studies with equivalent number of cases [10,11] 210 
although lower than others [7,10,20,21]. The only type found was HPV11, as reported by 211 
others [1,7,20]. No high risk types were found in our sample.  212 
The prevalence of HPV in SNIP with dysplasia or with SCC adjacent to the lesion is 213 
estimated to be higher than in SNIP without dysplasia [1], and more common in recurrent 214 
lesions [1]. We only included primary lesions, and only one case from Spain had dysplasia 215 
adjacent to the SNIP at diagnosis, and it was HPV positive. Three out of four HPV-positive 216 
patients in our series were ever smokers, although the association between the two 217 
variables was not statistically significant (p-value=0.631). The low HPV prevalence rates 218 
found in our series prevented us to further explore factors associated with HPV positivity. 219 
However, we noted a trend for HPV positive cases to affect the nasal cavity rather than the 220 
sinus and to involve younger people, in accordance with other studies [22]. 221 
We observed some differences between the two groups of patients, with Polish cases 222 
diagnosed at more recent periods (due to case selection), more advanced Krouse stages, 223 
and presenting a lower proportion of ever-smokers. Differences in some histopathological 224 
features were also observed between Polish and Spanish cases. However, due to the low 225 
number of cases, we decided to combine both groups to evaluate factors associated with 226 
recurrence and to address the differences between groups with the use of the strata function 227 
in Stata. Moreover, when accounting for such differences by stratifying the recurrence 228 




































































statistically significant differences between both groups. Although showing marked 230 
differences in HPV-AF in OPC for SNIPs, both series showed similar HPV prevalences, 231 
confirming that the variability in HPV detection rates in SNIPs is not explained by their 232 
different geographic origins, as it was already hypothesized in a previous metanalysis [10] 233 
The presence of dysplasia adjacent to the SNIP at diagnosis was the only factor associated 234 
with recurrence (HR: 18.83, 95%CI: 1.71-207.65), as it has been shown in previous studies 235 
[23], although only one case contributed to the estimation. A HR of 3.70 (95%CI 0.44-31.37) 236 
was observed for recurrence in HPV-positive cases, although not statistically significant. 237 
Other factors such as tobacco smoking or Krouse stage did not show any prognostic value 238 
for recurrence. However, tobacco use [1,7] and T3 vs T2 Krouse stages [8] have been 239 
previously reported to be related to recurrence. The low number of cases evaluated in this 240 
study could explain these discrepancies with the literature. A slight decreasing trend for 241 
recurrence in more recent years was observed, although it was not statistically significant.  242 
Only two cases (2.6%) progressed to invasive cancer during follow-up, and none of them 243 
were HPV-positive. Thus, we could not evaluate further the prognostic value of HPV 244 
positivity or other factors for malignant transformation. Different risk factors are suspected 245 
to be involved in malignant transformation of SNIPs and include HPV infection, tobacco 246 
smoking and occupational exposure [24]. In contrast, EGFR mutations have been observed 247 
to be a protective factor for malignant transformation of SNIPs [21,24]. However, many 248 
previous studies suggesting that HPV infection may play a role as a co-factor in the 249 
development of carcinoma ex-SNIP did not use biomarkers of biological activity of HPV such 250 
as the presence of E6/E7 mRNA transcripts or p16INK4a expression. Indeed, studies 251 
evaluating E6/E7 mRNA transcripts [25] or p16INK4a expression [26] in SNIPs did not find 252 
HPV as an etiological driver of SNIP development or progression to SCC. We did not 253 
observe p16INK4a expression in any HPV-DNA positive samples as expected, since all of 254 




































































samples for p16INK4a expression. We did neither evaluate further biomarkers of biological 256 
activity of HPV on HPV-DNA positive samples such as E6/E7 mRNA positivity nor do use 257 
techniques like laser capture microdissection, which combined with highly sensitive PCR 258 
allow assignment of a particular HPV genotype to an area of normal or abnormal epithelium 259 
[27]. 260 
The major limitation of the study was its relatively small sample size, which hampered us to 261 
evaluate factors associated with HPV-positivity, recurrence and malignant transformation. 262 
However, given the fact that SNIP is a relatively rare entity, few studies have reported results 263 
for series with equivalent number of primary SNIP cases consecutively diagnosed in two 264 
decades, like ours. Not all HPV-DNA negative cases were evaluated for p16INK4a expression 265 
and no evaluation of further biomarkers such as E6/E7 mRNA or EGFR was performed. A 266 
recent study showed that EGFR mutations and HPV infection represent essential, 267 
alternative oncogenic mechanisms in SNIP and SNIP-associated sinonasal SCC [21]. The 268 
study observed that SNIP progression was significantly associated with the presence of HPV 269 
infection and the absence of an EGFR mutation. We did not evaluate the prognostic value 270 
of the treatment received by the SNIP patient. However, a previous study did not find 271 
differences in recurrence by different types of interventions [9].  272 
The low prevalence of HPV-DNA found in SNIPs from two different countries suggests that 273 
HPV is not a main etiological factor for SNIP. The absence of association between HPV and 274 
the rest of herein evaluated factors and recurrence may suggest the involvement of other 275 
factors. Further research with larger number of patients and additional biomarkers is 276 
warranted to unequivocally assess the aetiology and prognosis of SNIP.  277 
TITLE’S LEGENDS  278 
Figure 1. Sinonasal inverted papilloma. Inverted growth pattern and absence of 279 




































































Figure 2. High power image shows non-keratinizing transitional epithelium covered by a 281 
layer of ciliated columnar epithelium. Infiltration by neutrophils is seen (hematoxylin-eosin 282 
10 x) 283 
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Identification number ________   Date   ______    Pathologist ________ 
 
1. HISTOLOGICAL DESCRIPTION OF THE LESION 




□ Presence of oncocytic cells 
□ Hyper-parakeratosis 
□ Presence of exophytic or papillary lesion adjacent to SNIP 
□ Dysplasia □ Mild  □ Moderate □ Severe/Carcinoma in situ 
Others: 
 
1.2. Intralesional polymorphonuclear infiltrate: 
□ No 
□ Yes    □ Mild    □ Moderate           □ Severe 
    
Inflammatory Perilesional infiltrate:                                                 
□ No 
□ Yes    □ Mild    □ Moderate           □ Severe 
 
1.3. Subepithelial stromal tissue 
□ Lax            □ Dense 
 
1.4. Other findings: 
 
2. DEFINITIVE DIAGNOSIS OF THE LESION 
□ Inverted  
□ Oncocytic. 
□ Exophytic 
□ Non-papillary lesion: 
□ Dysplasia           □ Mild  □ Moderate         □ Severe/Carcinoma in situ 
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3. Slides A&B 
□ Same                 □ Different 
 
4. Control 
□ Tissue: _____________                    
 
5. Final evaluation 
□ Adequate for HPV analysis 
□ Repeat sandwich technique 
□ Doubtful/Uncertain 
□ Discard for HPV analysis 
 
6. External quality control 
     □ Pathologist _____________ 
 
7. Internal quality control   
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(n = 33) 
No. (%) 
p-valuea 
Age at diagnosis 
  Mean (SD) 












  Male 
  Female 
 









Period of diagnosis 
  1995-2000 
  2001-2006 
  2007-2012 










0 ( 0.0) 
 
0 ( 0.0) 
0 ( 0.0) 




  Never smoker 
  Ever smoker 















  Never drinker 
  Ever drinker  














Previous history of HPV-related pathology   
  Yes 
  No 















  1 
  2 
  3 






















  Absence 












  Absence 












  Absence 












  Absence 






2 ( 4.3) 
 
32 (97.0) 
1 ( 3.0) 
1.000 
Papillar or exophytic lesion adjacent to SNIP 
  Absence 











Polymorphonuclear neutrophil inflammatory 
intralesional infiltrate  
  Absence  











1 ( 3.0) 
32 (97.0) 
1.000 
Polymorphonuclear neutrophil inflammatory perilesional 
infiltrate 
  Absence  















  No 
  Yes 












0 ( 0.0) 
0.268 














Months to recurrence 
  Median    











Progression to invasive cancer  
  No 
  Yes  
  Missing 
 
74 (93.7) 





3 ( 6.5) 
 
33 (100.0) 
0 ( 0.0) 
0 ( 0.0) 
0.502 
HPV positivity 
  No 











SNIP: Sinonasal Inverted Papilloma; SD: Standard deviation; aFischer exact test with the exception of age and months 
to recurrence. where t-student test has been used to compare the median values between populations. b: qreg (quantilte 
regression): test for equality of medians, equivalent for t-test for medians. 
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Table 2. Hazard ratios for recurrence in SNIP patients included 








Crude HR  
(95%CI) 
Hospital 
  Bellvitge (Spain) 



















  Male 
  Female 
 

















  Never smoker 











  Never drinker 










Previous history of HPV-related pathology   
  No  











  1 
  2 
  3 

















  Absence 











  Absence 











  Absence 










Papillar or exophytic lesion adyacent to SNIP 
  Absence 










Polymorphonuclear neutrophil inflammatory 
intralesional infiltrate (present in 74 cases) 
  Low 













Polymorphonuclear neutrophil inflammatory perilesional 
infiltrate (present in 75 cases) 
  Low 
  Moderate 
















Dysplasia at diagnosis adyacent to SNIP 
  Absence 










Progression to cancer during follow-up 
  No 











  No 










SNIP: Sinonasal Inverted Papilloma; aThree out of 79 cases did not have information regarding recurrence. bFirst row 
shows mean age of the sample with its standard deviation. 
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